Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to “Buy” Rating by StockNews.com
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other brokerages have also issued reports on RIGL. Piper Sandler boosted their target price on Rigel Pharmaceuticals from $15.00 […]
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other brokerages have also issued reports on RIGL. Piper Sandler boosted their target price on Rigel Pharmaceuticals from $15.00 […]
